What to Watch. WHO certificate bodes well for Lasa Supergen

Lasa Supergenerics has received WHO-GMP certificate for the unit situated at Mahad, Maharashtra, from the Commissioner of Food and Drug Administration. Following this, the entry to regulated business markets will commence shortly, the company said in a statement to the stock exchanges. The certificate is  valid (for active pharmaceutical ingredients - bulk drugs) till April 2020. Investors and shareholders of the company will track the development.